Drugplain

UVADEX 20 ug/mL

Methoxsalen · INJECTION, SOLUTION · Therakos LLC

No Recall History
Plain English

UVADEX is a injection, solution containing methoxsalen at 20 ug/mL, taken extracorporeal. Manufactured by Therakos LLC.

Key Facts

Brand Name
UVADEX
Generic Name
Methoxsalen
NDC Code (Product)
64067-216
Manufacturer
Therakos LLC
Strength
20 ug/mL
Dosage Form
INJECTION, SOLUTION
Route
EXTRACORPOREAL
Marketing Status
Application #
NDA020969
Drug Class
Photoactivated Radical Generator [EPC]; Psoralen [EPC]
Marketing Start
02/25/1999

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

product use in unapproved indication336 reports
off label use57 reports
condition aggravated41 reports
pulmonary embolism37 reports
death36 reports
disease progression35 reports
infection33 reports
hypotension30 reports
pyrexia27 reports
vomiting25 reports

Frequently Asked Questions

What is UVADEX used for?

UVADEX contains Methoxsalen. It is a injection, solution taken extracorporeal. Consult your doctor for specific uses.

Is UVADEX a controlled substance?

UVADEX is not classified as a controlled substance by the DEA.

What is the generic name for UVADEX?

The generic name for UVADEX is Methoxsalen. There are 1 other brand versions of Methoxsalen.

What is the NDC code for UVADEX 20 ug/mL?

The NDC (National Drug Code) for UVADEX 20 ug/mL is 64067-216, listed by Therakos LLC.

Product NDC

64067-216

Package NDC

64067-216-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)